ロード中...
Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers
Ovarian cancer is associated with a leukocyte infiltrate and high levels of chemokines such as CCL2. We tested the hypothesis that CCL2 inhibition can enhance chemotherapy with carboplatin and paclitaxel. Elevated CCL2 expression was found in three non‐MDR paclitaxel resistant ovarian cancer lines E...
保存先:
| 出版年: | Mol Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4801026/ https://ncbi.nlm.nih.gov/pubmed/24816187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.03.016 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|